Manipulating angiogenesis against vascular disease.
Gene therapy to stimulate the growth of new blood vessels is proving to be an effective way of bypassing occluded arteries and reestablishing blood flow to ischemic tissues. It could eventually replace surgical revascularization and angioplasty, which are not only more invasive but also plagued with restenosis, problems limiting long-term management of coronary artery and peripheral vascular disease.
Isner
J M
JM
Tufts University School of Medicine, Boston, USA.
D000328:Adult; D016228:Endothelial Growth Factors / Q000502:physiology / Q000627:therapeutic use*; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008222:Lymphokines / Q000502:physiology / Q000627:therapeutic use*; D008297:Male; D018919:Neovascularization, Physiologic / Q000187:drug effects* / Q000235:genetics; D015854:Up-Regulation; D014652:Vascular Diseases / Q000628:therapy*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors